Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Predictive Oncology ROA 2010-2025 | POAI

Current and historical return on assets (ROA) values for Predictive Oncology (POAI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Predictive Oncology ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $-0.01B $0.01B -137.93%
2024-12-31 $-0.01B $0.01B -141.18%
2024-09-30 $-0.01B $0.01B -120.93%
2024-06-30 $-0.01B $0.01B -96.30%
2024-03-31 $-0.01B $0.01B -87.50%
2023-12-31 $-0.01B $0.01B -66.67%
2023-09-30 $-0.02B $0.02B -80.00%
2023-06-30 $-0.02B $0.02B -72.38%
2023-03-31 $-0.03B $0.03B -83.33%
2022-12-31 $-0.03B $0.03B -74.07%
2022-09-30 $-0.03B $0.03B -65.36%
2022-06-30 $-0.03B $0.04B -60.82%
2022-03-31 $-0.02B $0.04B -39.58%
2021-12-31 $-0.02B $0.04B -41.67%
2021-09-30 $-0.02B $0.05B -57.14%
2021-06-30 $-0.03B $0.06B -74.07%
2021-03-31 $-0.03B $0.04B -99.05%
2020-12-31 $-0.03B $0.01B -120.00%
2020-09-30 $-0.03B $0.03B -121.21%
2020-06-30 $-0.03B $0.03B -101.89%
2020-03-31 $-0.02B $0.03B -79.28%
2019-12-31 $-0.02B $0.02B -87.91%
2019-09-30 $-0.01B $0.03B -49.32%
2019-06-30 $-0.01B $0.03B -69.57%
2019-03-31 $-0.01B $0.01B -244.44%
2018-12-31 $-0.01B $0.00B -210.53%
2018-09-30 $-0.01B $0.01B -168.42%
2018-06-30 $-0.01B $0.00B -141.18%
2018-03-31 $-0.01B $0.01B -155.56%
2017-12-31 $-0.01B $0.00B -141.18%
2017-09-30 $-0.01B $0.00B -150.00%
2017-06-30 $-0.01B $0.01B -160.00%
2017-03-31 $-0.01B $0.01B -184.62%
2016-12-31 $-0.01B $0.00B -233.33%
2016-09-30 $-0.01B $0.00B -213.33%
2016-06-30 $-0.01B $0.00B -152.38%
2016-03-31 $-0.01B $0.00B -126.32%
2015-12-31 $0.00B $0.01B -100.00%
2015-09-30 $0.00B $0.01B -145.45%
2015-06-30 $0.00B $0.00B -400.00%
2015-03-31 $-0.01B $0.00B -500.00%
2014-12-31 $-0.01B $0.00B -700.00%
2014-09-30 $-0.01B $0.00B -700.00%
2014-06-30 $-0.01B $0.00B -1000.00%
2014-03-31 $-0.01B $0.00B -1200.00%
2013-12-31 $-0.01B $0.00B -1200.00%
2013-09-30 $-0.01B $0.00B -1800.00%
2013-06-30 $-0.01B $0.00B -3200.00%
2013-03-31 $-0.01B $0.00B -3600.00%
2012-12-31 $-0.01B $0.00B 0.00%
2012-09-30 $-0.01B $0.00B 0.00%
2012-06-30 $-0.01B $0.00B 0.00%
2012-03-31 $-0.01B $0.00B 0.00%
2011-12-31 $0.00B $0.00B 0.00%
2011-09-30 $0.00B $0.00B 0.00%
2011-06-30 $0.00B $0.00B 0.00%
2011-03-31 $0.00B $0.00B 0.00%
2010-12-31 $0.00B $0.00B 0.00%
2010-09-30 $0.00B $0.00B 0.00%
2010-06-30 $0.00B $0.00B 0.00%
2010-03-31 $0.00B $0.00B 0.00%
2009-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.008B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.427B 59.33
Hims & Hers Health (HIMS) United States $12.608B 131.00
Tempus AI (TEM) United States $10.745B 0.00
IRhythm Technologies (IRTC) United States $4.683B 0.00
Inspire Medical Systems (INSP) United States $4.012B 62.68
Hinge Health (HNGE) United States $3.034B 0.00
Privia Health (PRVA) United States $2.827B 193.25
Enovis (ENOV) United States $1.816B 10.12
Schrodinger (SDGR) United States $1.807B 0.00
Phreesia (PHR) United States $1.595B 0.00
Clover Health Investments (CLOV) United States $1.555B 0.00
Omnicell (OMCL) United States $1.452B 25.62
Azenta (AZTA) United States $1.316B 61.17
10x Genomics (TXG) United States $1.160B 0.00
Fulgent Genetics (FLGT) United States $0.652B 0.00
Claritev (CTEV) United States $0.650B 0.00
Butterfly Network (BFLY) United States $0.613B 0.00
Talkspace (TALK) United States $0.550B 164.50
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.403B 0.00
Outset Medical (OM) United States $0.371B 0.00
TruBridge (TBRG) United States $0.358B 794.00
Health Catalyst (HCAT) United States $0.285B 0.00
Nyxoah SA (NYXH) Belgium $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
KORU Medical Systems (KRMD) United States $0.142B 0.00
EUDA Health Holdings (EUDA) Singapore $0.128B 0.00
Pulmonx (LUNG) United States $0.128B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.092B 3.52
111 (YI) China $0.073B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
Zepp Health (ZEPP) Netherlands $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00